UK Markets open in 7 hrs 39 mins

Novozymes A/S (NZYM-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
454.00+1.50 (+0.33%)
At close: 04:59PM CEST
Full screen
Previous close452.50
Bid454.00 x 0
Ask456.80 x 0
Day's range453.00 - 466.40
52-week range379.30 - 545.80
Avg. volume295,174
Market cap125.731B
Beta (5Y monthly)0.29
PE ratio (TTM)40.11
EPS (TTM)11.32
Earnings dateN/A
Forward dividend & yield5.50 (1.18%)
Ex-dividend date17 Mar 2022
1y target est423.42
  • Globe Newswire

    Novozymes delivers strong half year results and narrows full-year outlook upwards

    Novozymes delivered solid earnings and double-digit organic sales growth in both the first half and in the second quarter. Despite the volatile market environment, the company narrows its full-year organic sales outlook upwards from 4-8% to now 6-8% and raises EBIT-margin expectations from 25-26% to now 26-27%. COPENHAGEN, Denmark – August 11, 2022. Novozymes delivers 10% organic sales growth and an EBIT-margin of 26% in the first half of the year, with 18% organic sales growth in DKK. Good mome

  • Globe Newswire

    Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming cost

    Novozymes has experienced unprecedented cost-inflation on raw materials, energy, and logistics. To recover these headwinds, substantial price increases will be implemented. COPENHAGEN, Denmark – 15 July 2022. Novozymes has been able to partially shield its customers from a large part of the global challenges, securing business continuity and high price stability relative to other suppliers. However, Novozymes will further substantially increase prices at a level at least in line with the current

  • Zacks

    AXTA vs. NVZMY: Which Stock Is the Better Value Option?

    AXTA vs. NVZMY: Which Stock Is the Better Value Option?